SurvivX, developing a novel treatment against sepsis, was selected by INCATE Incubator community
Nijmegen, 12th September 2023 - By the occasion of the [...]
Nijmegen, 12th September 2023 - By the occasion of the [...]
The next INCATE's Selection Committee is coming up and we [...]
2023 has reached its final quarter and there are still [...]
6th September 2023 - INCATE (the INCubator for Antibacterial Therapies [...]
INCATE PRESS RELEASE 08, May 2023 For immediate release INCATE [...]
All photographs - Copyright - eventfotografen.com/bamconn GmbH The AMR-Conference, Europe’s [...]
The INCATE Selection Committee selected another 5 ventures for Stage [...]
The INCATE team is expanding and we have three positions [...]
Who invests in Antibiotics? What are they looking for? How [...]
We are excited to announce our comment highlighting the INCATE [...]